PA8518601A1 - Combinaciones de carboxialquileter-inhibidor de acat - Google Patents

Combinaciones de carboxialquileter-inhibidor de acat

Info

Publication number
PA8518601A1
PA8518601A1 PA20018518601A PA8518601A PA8518601A1 PA 8518601 A1 PA8518601 A1 PA 8518601A1 PA 20018518601 A PA20018518601 A PA 20018518601A PA 8518601 A PA8518601 A PA 8518601A PA 8518601 A1 PA8518601 A1 PA 8518601A1
Authority
PA
Panama
Prior art keywords
acat
carboxialquileter
inhibitor combinations
rented
formula
Prior art date
Application number
PA20018518601A
Other languages
English (en)
Spanish (es)
Inventor
Bruce Jeffrey Auerbach
Donna Lee Zobel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PA8518601A1 publication Critical patent/PA8518601A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PA20018518601A 2000-06-07 2001-06-05 Combinaciones de carboxialquileter-inhibidor de acat PA8518601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21005600P 2000-06-07 2000-06-07

Publications (1)

Publication Number Publication Date
PA8518601A1 true PA8518601A1 (es) 2002-07-30

Family

ID=22781424

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018518601A PA8518601A1 (es) 2000-06-07 2001-06-05 Combinaciones de carboxialquileter-inhibidor de acat

Country Status (14)

Country Link
EP (1) EP1292363A2 (ja)
JP (1) JP2003535125A (ja)
AR (1) AR034255A1 (ja)
AU (1) AU2001263003A1 (ja)
BR (1) BR0111428A (ja)
CA (1) CA2413906A1 (ja)
GT (1) GT200100106A (ja)
MX (1) MXPA02010762A (ja)
PA (1) PA8518601A1 (ja)
PE (1) PE20020265A1 (ja)
SV (1) SV2002000466A (ja)
TN (1) TNSN01085A1 (ja)
UY (1) UY26752A1 (ja)
WO (1) WO2001093845A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387236B2 (en) 2001-10-09 2008-06-17 Delaware Capital Formation, Inc. Dispensing of currency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833971T2 (de) * 1998-01-28 2006-11-02 Warner-Lambert Co. Llc Verfahren zur behandlung der alzheimerschen krankheit

Also Published As

Publication number Publication date
JP2003535125A (ja) 2003-11-25
GT200100106A (es) 2002-05-20
BR0111428A (pt) 2003-06-10
WO2001093845A3 (en) 2002-10-10
TNSN01085A1 (en) 2005-11-10
AR034255A1 (es) 2004-02-18
EP1292363A2 (en) 2003-03-19
AU2001263003A1 (en) 2001-12-17
CA2413906A1 (en) 2001-12-13
WO2001093845A2 (en) 2001-12-13
SV2002000466A (es) 2002-04-03
UY26752A1 (es) 2001-07-31
PE20020265A1 (es) 2002-04-19
MXPA02010762A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
ECSP024382A (es) Inhibidores de proteasa de serina
AR027788A1 (es) Proceso de desinfectar una superficie dura con una composicion que comprende aceite de canela y/o un activo de este
DE69827821D1 (de) Synergistisch,analgetische zusammensetzung mit opiod-analgetika und zyklooxygenase-2 inhibitoren
CR7849A (es) Agente para la prevencion o tratamiento de neuropatias
DK1509232T3 (da) Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
EA200201175A1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
GT200100152A (es) Nueva composicion farmaceutica para el tratamiento de la obesidad.
GT200100132A (es) Derivados de pirazol
CR9465A (es) Compuestos mejorados farmacocineticamente
GT200100083A (es) Composiciones polpeptidas toxicas para insectos antonomos y metodos para su uso.
BR9612661A (pt) Utilização de uma combinaç i de tensoatives agentes quelantes e óleos essenciais para desinfecção eficaz
SV2007002526A (es) Diarilsulfona sulfonamidas y el uso de las mismas ref. p1018
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
PA8521801A1 (es) Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra
CY1111566T1 (el) Συνθεση που περιεχει ελαιο κιτρονελλας ιαβας και η χρησιμοποιηση της για την απωθηση εντομων
ME00674B (me) Disperzioni preparati sa sadržajem inhibitora lipaza
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
TW200730190A (en) New combination to treat liver fibrosis
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
PA8518601A1 (es) Combinaciones de carboxialquileter-inhibidor de acat
BR0108980A (pt) Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina